NCT02253953View on ClinicalTrials.gov

Pharmacokinetics of Single Doses of BILR 355 BS Given With Ritonavir in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

December 31, 2003

Conditions
Healthy
Interventions
DRUG

BILR 355 BS, D1

DRUG

BILR 355 BS, D2

DRUG

BILR 355 BS, D3

DRUG

BILR 355 BS, D4

DRUG

BILR 355 BS, D5

DRUG

BILR 355 BS, D6

DRUG

BILR 355 BS, D7

DRUG

BILR 355 BS, D8

DRUG

BILR 355 BS, D10

DRUG

Placebo

OTHER

high-fat breakfast

DRUG

Ritonavir

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY